Heidi counsels clients in patent related matters including international patent portfolio management and due diligence analyses. Heidi’s practice focuses on patent prosecution in technical areas of molecular biology, medical device and medical diagnostics. Heidi’s prosecution experience includes preparing and prosecuting applications in technologies including RNA interference, recombinant nucleic acid and protein technologies, mutational analysis, antibody therapies, transgenic animals and plants, therapeutic vectors, stem cell therapies, and gene therapy.
Heidi counsels a diverse group of clients from corporate clients of all sizes, university clients and start-ups. Heidi has prosecuted over 1000 patent applications in the U.S. and worldwide.
Prior to joining the firm in 2002, Heidi’s non-legal experience included research positions at Howard Hughes Medical Institute, University of Michigan and the Ohio State University.
Articles in the National Law Review database by Heidi Dare